Episode #239: Maximizing the Potential of GLP-1 Medications: Dr. Gus Vickery's Strategies for Long-Term Success

In today’s episode, Dr. Gus Vickery and I discuss the effective use of GLP-1 agonist medications like semaglutide and tirzepatide for sustainable weight loss. He emphasizes the need for a mindset shift, viewing these drugs as powerful tools to catalyze positive changes rather than easy fixes or crutches. Dr. Vickery explains that these medications provide leverage to implement foundational healthy habits and that the key to success lies in focusing on nutrient sufficiency, not just calorie restriction.

Episode #129: Weight Loss Results with New GLP-1 Agonist, Mounjaro & Ozempic Comparison

In this episode, Caleb Greer is back to discuss one of the hottest current topics, GLP-1 agonists! We talk about the classic semaglutide as well as deep dive into the new darling of weight loss and blood sugar regulation/type 2 diabetes, Tirzepatide (Mounjaro). If you have been wondering how dosing translates, what results can be expected, the risks and how side effects differ, or if you are a good candidate, this episode will be a great precursor to speaking to your provider!

Covering the latest research directly from the experts across peptides, epigenetics, actionable biohacking, data-driven healthtech & more.